Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

被引:488
作者
Cleare, Anthony [1 ]
Pariante, C. M. [2 ]
Young, A. H. [3 ]
Anderson, I. M. [4 ]
Christmas, D. [5 ]
Cowen, P. J. [6 ]
Dickens, C. [7 ,8 ]
Ferrier, I. N. [9 ]
Geddes, J. [10 ]
Gilbody, S. [11 ]
Haddad, P. M. [12 ]
Katona, C. [13 ]
Lewis, G. [13 ]
Malizia, A. [14 ]
McAllister-Williams, R. H. [15 ]
Ramchandani, P. [16 ]
Scott, J. [17 ]
Taylor, D. [18 ]
Uher, R. [19 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Affect Disorders, Psychopharmacol & Affect Disorders, London SE5 8AF, England
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Affect Disorders, Biol Psychiat, London SE5 8AF, England
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Affect Disorders, Psychiat & Chair Mood Disorders, London SE5 8AF, England
[4] Univ Manchester, Dept Psychiat, Manchester, Lancs, England
[5] Univ Dundee, Ninewells Hosp & Med Sch, Adv Intervent Serv, Dundee DD1 9SY, Scotland
[6] Warneford Hosp, Univ Dept Psychiat, Psychopharmacol Res Unit, Psychopharmacol, Oxford OX3 7JX, England
[7] Univ Exeter, Sch Med, Psychol Med, Exeter, Devon, England
[8] Devon Partnership Trust, Exeter, Devon, England
[9] Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[10] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England
[11] Univ York, Dept Hlth Sci, Hull York Med Sch, MHARG, York YO10 5DD, N Yorkshire, England
[12] Greater Manchester West Mental Hlth NHS Fdn Trust, Salford, Lancs, England
[13] UCL, Div Psychiat, London, England
[14] North Bristol NHS Trust, Southmead Hosp, Rosa Burden Ctr, Bristol, Avon, England
[15] Newcastle Univ, Royal Victoria Infirm, Inst Neurosci, Clin Psychopharmacol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[16] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, Child & Adolescent Psychiat, London, England
[17] Newcastle Univ, Inst Neurosci, Psychol Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[18] Kings Coll London, Psychopharmacol, London SE5 8AF, England
[19] Dalhousie Univ, Dept Psychiat, Canada Res Chair Early Intervent, Halifax, NS, Canada
关键词
Antidepressants; depression; depressive disorder; treatment; evidence-based guidelines; SEROTONIN-REUPTAKE INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; TREATMENT-RESISTANT DEPRESSION; RANDOMIZED CONTROLLED-TRIAL; STAR-ASTERISK-D; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE-STIMULATION; PRIMARY-CARE PATIENTS; LATE-LIFE DEPRESSION;
D O I
10.1177/0269881115581093
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A revision of the 2008 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken in order to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in September 2012. Key areas in treating depression were reviewed and the strength of evidence and clinical implications were considered. The guidelines were then revised after extensive feedback from participants and interested parties. A literature review is provided which identifies the quality of evidence upon which the recommendations are made. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse and stopping treatment. Significant changes since the last guidelines were published in 2008 include the availability of new antidepressant treatment options, improved evidence supporting certain augmentation strategies (drug and non-drug), management of potential long-term side effects, updated guidance for prescribing in elderly and adolescent populations and updated guidance for optimal prescribing. Suggestions for future research priorities are also made.
引用
收藏
页码:459 / 525
页数:67
相关论文
共 740 条
[41]   Screening for. depression in primary care with two verbally asked questions: cross sectional study [J].
Arroll, B ;
Khin, N ;
Kerse, N .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7424) :1144-1146
[42]   Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders [J].
Baca, E ;
Garcia-Garcia, M ;
Porras-Chavarino, A .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (01) :57-65
[43]   Impact of pain on depression treatment response in primary care [J].
Bair, MJ ;
Robinson, RL ;
Eckert, GJ ;
Stang, PE ;
Croghan, TW ;
Kroenke, K .
PSYCHOSOMATIC MEDICINE, 2004, 66 (01) :17-22
[44]   Two-Year Outcome of Vagus Nerve Stimulation in Treatment-Resistant Depression [J].
Bajbouj, Malek ;
Merkl, Angela ;
Schlaepfer, Thomas E. ;
Frick, Caroline ;
Zobel, Astrid ;
Maier, Wolfgang ;
O'Keane, Veronica ;
Corcoran, Ciaran ;
Adolfsson, Rolf ;
Trimble, Michael ;
Rau, Harald ;
Hoff, Hans-Joachim ;
Padberg, Frank ;
Mueller-Siecheneder, Florian ;
Audenaert, Kurt ;
van den Abbeele, Dirk ;
Matthews, Keith ;
Christmas, David ;
Eljamel, Sam ;
Heuser, Isabella .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (03) :273-281
[45]   Illness Risk Following Rapid Versus Gradual Discontinuation of Antidepressants [J].
Baldessarini, Ross J. ;
Tondo, Leonardo ;
Ghiani, Carmen ;
Lepri, Beatrice .
AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (08) :934-941
[46]   Escitalopram therapy for major depression and anxiety disorders [J].
Baldwin, David S. ;
Reines, Elin Heldbo ;
Guiton, Christina ;
Weiller, Emmanuelle .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (10) :1583-1592
[47]   Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology [J].
Baldwin, DS ;
Anderson, IM ;
Nutt, DJ ;
Bandelow, B ;
Bond, A ;
Davidson, JRT ;
den Boer, JA ;
Fineberg, NA ;
Knapp, M ;
Scott, J ;
Wittchen, HU .
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (06) :567-596
[48]  
Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P47
[49]   Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine [J].
Banerjee, S. ;
Hellier, J. ;
Romeo, R. ;
Dewey, M. ;
Knapp, M. ;
Ballard, C. ;
Baldwin, R. ;
Bentham, P. ;
Fox, C. ;
Holmes, C. ;
Katona, C. ;
Lawton, C. ;
Lindesay, J. ;
Livingston, G. ;
McCrae, N. ;
Moniz-Cook, E. ;
Murray, J. ;
Nurock, S. ;
Orrell, M. ;
O'Brien, J. ;
Poppe, M. ;
Thomas, A. ;
Walwyn, R. ;
Wilson, K. ;
Burns, A. .
HEALTH TECHNOLOGY ASSESSMENT, 2013, 17 (07) :1-+
[50]  
BARBATO A, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004188.PUB2